Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin Transplantation | 3 | 2024 | 1083 | 1.260 |
Why?
|
| Wound Healing | 6 | 2024 | 2805 | 1.050 |
Why?
|
| Skin | 4 | 2024 | 4484 | 1.050 |
Why?
|
| Amniotic Fluid | 8 | 2011 | 378 | 0.810 |
Why?
|
| Weight-Bearing | 1 | 2024 | 532 | 0.770 |
Why?
|
| Epidermis | 1 | 2021 | 528 | 0.590 |
Why?
|
| Embryoid Bodies | 2 | 2011 | 65 | 0.460 |
Why?
|
| Bioreactors | 1 | 2015 | 247 | 0.450 |
Why?
|
| Fibrin | 1 | 2015 | 507 | 0.410 |
Why?
|
| Embryonic Stem Cells | 4 | 2011 | 1263 | 0.380 |
Why?
|
| Pluripotent Stem Cells | 3 | 2013 | 799 | 0.360 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2011 | 2805 | 0.350 |
Why?
|
| Stress, Mechanical | 1 | 2015 | 1674 | 0.350 |
Why?
|
| Organogenesis | 1 | 2011 | 215 | 0.340 |
Why?
|
| Swine | 4 | 2024 | 5915 | 0.340 |
Why?
|
| Hydrogels | 1 | 2015 | 720 | 0.330 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 1726 | 0.290 |
Why?
|
| Phenotype | 1 | 2024 | 16592 | 0.260 |
Why?
|
| High-Energy Shock Waves | 2 | 2014 | 33 | 0.230 |
Why?
|
| Foot Ulcer | 1 | 2024 | 63 | 0.220 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2011 | 2898 | 0.210 |
Why?
|
| Skin Physiological Phenomena | 1 | 2024 | 188 | 0.210 |
Why?
|
| Myocytes, Cardiac | 1 | 2011 | 1668 | 0.200 |
Why?
|
| Antigens, Differentiation | 2 | 2015 | 909 | 0.200 |
Why?
|
| Protein Kinases | 4 | 2009 | 1608 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 4 | 2011 | 319 | 0.190 |
Why?
|
| Electron Transport Complex IV | 1 | 2021 | 190 | 0.180 |
Why?
|
| Fibroblasts | 3 | 2021 | 4142 | 0.180 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2010 | 2872 | 0.180 |
Why?
|
| Bandages | 1 | 2022 | 269 | 0.180 |
Why?
|
| Cell Differentiation | 6 | 2017 | 11530 | 0.170 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 4948 | 0.170 |
Why?
|
| Foot | 1 | 2024 | 575 | 0.170 |
Why?
|
| Receptors, Purinergic P2Y2 | 1 | 2019 | 17 | 0.170 |
Why?
|
| Stem Cells | 4 | 2017 | 3524 | 0.160 |
Why?
|
| Transplantation, Autologous | 2 | 2021 | 2115 | 0.160 |
Why?
|
| Paracrine Communication | 1 | 2020 | 277 | 0.150 |
Why?
|
| TOR Serine-Threonine Kinases | 10 | 2011 | 2057 | 0.150 |
Why?
|
| Apoptosis | 2 | 2011 | 9490 | 0.130 |
Why?
|
| Cell Line | 8 | 2015 | 15601 | 0.130 |
Why?
|
| Serine | 2 | 2010 | 831 | 0.130 |
Why?
|
| RNA, Small Interfering | 3 | 2019 | 3430 | 0.120 |
Why?
|
| Calcinosis | 1 | 2023 | 1469 | 0.120 |
Why?
|
| Animals | 17 | 2024 | 168475 | 0.120 |
Why?
|
| Multipotent Stem Cells | 1 | 2014 | 200 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2020 | 1651 | 0.100 |
Why?
|
| Neovascularization, Physiologic | 1 | 2019 | 1349 | 0.100 |
Why?
|
| Adenosine Triphosphate | 2 | 2017 | 1989 | 0.100 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 615 | 0.100 |
Why?
|
| Germ Layers | 1 | 2011 | 72 | 0.100 |
Why?
|
| Cell Size | 2 | 2011 | 624 | 0.090 |
Why?
|
| Methylmercury Compounds | 1 | 2011 | 103 | 0.090 |
Why?
|
| Cells, Cultured | 8 | 2023 | 18966 | 0.090 |
Why?
|
| Aortic Valve Stenosis | 1 | 2023 | 2001 | 0.090 |
Why?
|
| Ribosomal Protein S6 | 1 | 2010 | 71 | 0.090 |
Why?
|
| Biological Assay | 1 | 2013 | 626 | 0.090 |
Why?
|
| Teratoma | 1 | 2013 | 404 | 0.090 |
Why?
|
| Cell Proliferation | 3 | 2020 | 10451 | 0.090 |
Why?
|
| Muscle Proteins | 1 | 2015 | 1154 | 0.080 |
Why?
|
| Adult Stem Cells | 1 | 2011 | 221 | 0.080 |
Why?
|
| Mice | 8 | 2024 | 81539 | 0.080 |
Why?
|
| Multiprotein Complexes | 3 | 2009 | 1120 | 0.080 |
Why?
|
| Cytoplasm | 2 | 2010 | 1510 | 0.080 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2008 | 90 | 0.080 |
Why?
|
| Regenerative Medicine | 1 | 2011 | 306 | 0.080 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 647 | 0.070 |
Why?
|
| Mitochondria | 1 | 2021 | 3624 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2011 | 2919 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 1486 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2019 | 4431 | 0.070 |
Why?
|
| Embryonic Development | 1 | 2011 | 721 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2019 | 3549 | 0.070 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2009 | 655 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 1612 | 0.060 |
Why?
|
| Sirolimus | 2 | 2009 | 1533 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 1971 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2017 | 3313 | 0.060 |
Why?
|
| Cytokines | 1 | 2020 | 7396 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2009 | 1062 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 18255 | 0.060 |
Why?
|
| Cell Nucleus | 2 | 2010 | 2910 | 0.060 |
Why?
|
| Phosphorylation | 5 | 2019 | 8321 | 0.060 |
Why?
|
| Humans | 27 | 2024 | 761596 | 0.060 |
Why?
|
| Biglycan | 1 | 2023 | 10 | 0.060 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2008 | 604 | 0.050 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2023 | 98 | 0.050 |
Why?
|
| Female | 8 | 2024 | 392705 | 0.050 |
Why?
|
| Tuberous Sclerosis | 1 | 2009 | 1030 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2009 | 2932 | 0.050 |
Why?
|
| Leukemia | 1 | 2009 | 1522 | 0.050 |
Why?
|
| Platelet Aggregation | 2 | 2019 | 771 | 0.050 |
Why?
|
| Kidney | 3 | 2011 | 7048 | 0.050 |
Why?
|
| Proteins | 3 | 2009 | 6032 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2011 | 16990 | 0.040 |
Why?
|
| Immunosuppressive Agents | 2 | 2009 | 4176 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 2011 | 2472 | 0.040 |
Why?
|
| Carrier Proteins | 2 | 2009 | 4937 | 0.040 |
Why?
|
| Signal Transduction | 4 | 2010 | 23447 | 0.040 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2009 | 103 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 2020 | 522 | 0.040 |
Why?
|
| Angiopoietin-2 | 1 | 2019 | 173 | 0.040 |
Why?
|
| Cyclin D1 | 2 | 2011 | 451 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2019 | 473 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2019 | 477 | 0.040 |
Why?
|
| Rats | 6 | 2014 | 23741 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2019 | 658 | 0.030 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2019 | 284 | 0.030 |
Why?
|
| RNA Interference | 2 | 2019 | 2832 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2019 | 546 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 11904 | 0.030 |
Why?
|
| Collective Bargaining | 1 | 1975 | 3 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2019 | 727 | 0.030 |
Why?
|
| Cicatrix | 1 | 2020 | 798 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2014 | 8181 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2023 | 1955 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2014 | 740 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2017 | 1869 | 0.030 |
Why?
|
| Hospital Administration | 1 | 1975 | 353 | 0.020 |
Why?
|
| Cyclin A | 1 | 2011 | 60 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2017 | 1330 | 0.020 |
Why?
|
| Zebrafish | 1 | 2023 | 3008 | 0.020 |
Why?
|
| Male | 6 | 2024 | 360846 | 0.020 |
Why?
|
| Food Contamination | 1 | 2011 | 191 | 0.020 |
Why?
|
| Fibroblast Growth Factor 4 | 1 | 2009 | 28 | 0.020 |
Why?
|
| Integrin alphaV | 1 | 2009 | 54 | 0.020 |
Why?
|
| Cell Transplantation | 1 | 2011 | 472 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2017 | 1935 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 2009 | 239 | 0.020 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2009 | 223 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2009 | 255 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2010 | 670 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2014 | 3597 | 0.020 |
Why?
|
| Gene Expression | 2 | 2011 | 7581 | 0.020 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2008 | 106 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2010 | 931 | 0.020 |
Why?
|
| Cell Movement | 1 | 2020 | 5205 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2009 | 618 | 0.020 |
Why?
|
| Digitoxin | 1 | 1975 | 19 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 1646 | 0.020 |
Why?
|
| Transcription Factors | 3 | 2010 | 12130 | 0.020 |
Why?
|
| Microsomes, Liver | 1 | 1975 | 173 | 0.020 |
Why?
|
| Protein Transport | 1 | 2010 | 1967 | 0.010 |
Why?
|
| Tubulin | 1 | 2008 | 693 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 2010 | 933 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1975 | 210 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2009 | 1342 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2008 | 1687 | 0.010 |
Why?
|
| Transfection | 1 | 2010 | 5774 | 0.010 |
Why?
|
| Environmental Pollutants | 1 | 2011 | 1277 | 0.010 |
Why?
|
| Epinephrine | 1 | 1975 | 792 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2009 | 2448 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2010 | 2856 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1976 | 1241 | 0.010 |
Why?
|
| Adult | 4 | 2023 | 221210 | 0.010 |
Why?
|
| Neoplasms | 1 | 2008 | 22173 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2008 | 2827 | 0.010 |
Why?
|
| Protein Binding | 1 | 2009 | 9353 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 1976 | 2024 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2008 | 3677 | 0.010 |
Why?
|
| Internship and Residency | 1 | 1975 | 5882 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1975 | 2479 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2009 | 7859 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 8554 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1975 | 6567 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 17904 | 0.010 |
Why?
|
| Pregnancy | 1 | 2010 | 29890 | 0.000 |
Why?
|
| Alzheimer Disease | 1 | 2008 | 8601 | 0.000 |
Why?
|
| Digitoxigenin | 1 | 1975 | 9 | 0.000 |
Why?
|
| Dihydroergotamine | 1 | 1975 | 19 | 0.000 |
Why?
|
| Lysergic Acid Diethylamide | 1 | 1975 | 47 | 0.000 |
Why?
|
| Chromatography, Thin Layer | 1 | 1975 | 213 | 0.000 |
Why?
|
| Hydroxylation | 1 | 1975 | 137 | 0.000 |
Why?
|
| Drug Stability | 1 | 1975 | 291 | 0.000 |
Why?
|
| NADP | 1 | 1975 | 227 | 0.000 |
Why?
|
| Cats | 1 | 1976 | 975 | 0.000 |
Why?
|
| Texas | 1 | 1975 | 404 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2008 | 12149 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1975 | 1416 | 0.000 |
Why?
|
| Dogs | 1 | 1976 | 3839 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1975 | 2496 | 0.000 |
Why?
|
| Rabbits | 1 | 1975 | 4772 | 0.000 |
Why?
|
| Temperature | 1 | 1975 | 2226 | 0.000 |
Why?
|
| Kinetics | 1 | 1975 | 6374 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1975 | 2413 | 0.000 |
Why?
|
| United States | 1 | 1975 | 72340 | 0.000 |
Why?
|
| Hypertension | 1 | 1976 | 8540 | 0.000 |
Why?
|
| Time Factors | 1 | 1975 | 39969 | 0.000 |
Why?
|
Concepts
(187)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_